1. In Vivo

Selected Start-Ups Founded in 1999 (4/99)

This section summarizes the technologies of several medical companies founded within the last year. Advanced Drug Delivery Technoloiges, founded with Novartis Venture Fund financing, is developing liquid and solid dosage formulations for NCE's and generic compounds. Altea Development Corp. has a patch to enable delivery of drugs through the skin. Institute for Diagnostic Research provides customized assay development for the pharmaceutical industry. Brain cells may be able to regenerate, believes NeuroNova of Sweden. Vasca has spun-out NxStage medical to improve dialysis treatment technologies.

Advanced Drug Delivery Technologies AG , founded with Novartis Venture Fund financing, is a Swiss start-up focused on developing liquid and solid dosage formulations for NCEs and generic compounds from the development phase to commercialization. Its technologies come from alliances with Glatt GMBH and the Phares Group of Companies (UK). Peter van Hoogevest, professor at the University of Basel , with former drug delivery experience at Ciba-Novartis (Basel), is the CEO.

Atlanta-based Altea Development Corp. is developing a needle-free drug delivery product based on its MicroPor patch system that opens tiny...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from In Vivo